advertising
-
1.
Belyayeva E, Gregoriou S, Chalikias J, et al: The impact of nail disorders on quality of life. Eur J Dermatol 23: 366, 2013.
-
2.
Gurel MS, Yanik M, Simsek Z, et al: Quality of life instrument for Turkish people with skin diseases. Int J Dermatol 44: 933, 2005.
-
3.
Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 67: 361, 1983.
-
4.
Aydemir O: Hastane anksiyete ve depresyon olcegi Turkce formunun gecerlilik ve guvenilirligi. Turk Psikiyatri Derg 8: 187, 1997.
-
5.
Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 30: 473, 1992.
-
6.
Wewers ME, Lowe NK: A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health 13: 227, 1990.
-
7.
Reich A, Szepietowski JC: Health-related quality of life in patients with nail disorders. Am J Clin Dermatol 12: 313, 2011.
-
8.
Tabolli S, Alessandroni L, Gaido J, et al: Health-related quality of life and nail disorders. Acta Derm Venereol 87: 255, 2007.
-
9.
Szepietowski JC, Reich A, Pacan P, et al: Evaluation of quality of life in patients with toenail onychomycosis by Polish version of an international onychomycosis‐specific questionnaire. J Eur Acad Dermatol Venereol 21: 491, 2007.
-
10.
DeBrule MB: Operative treatment of ingrown toenail by nail fold resection without matricectomy. JAPMA 105: 295, 2015.
-
11.
Pollak RA: Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis. JAPMA 104: 568, 2014.
-
12.
Kim J-Y: Matrixplasty for the treatment of severe incurved toenail with growth plate deformity. JAPMA 102: 198, 2012.
-
13.
Çakmur H, Derviş E: The relationship between quality of life and the severity of psoriasis in Turkey. Eur J Dermatol 25: 169, 2015.
-
14.
Balci DD, Inandi T, Dogramaci CA, et al: DLQI scores in patients with keloids and hypertrophic scars: a prospective case control study. J Dtsch Dermatol Ges 7: 688, 2009.
-
15.
Ilgen E, Derya A: There is no correlation between acne severity and AQOLS/DLQI scores. J Dermatol 32: 705, 2005.
-
16.
Turan Ç, Şahin T, Ekşioğlu HM: How effective is cryotherapy applied to the nail fold in ingrown toenails? Acta Dermatovenerol Alp Pannonica Adriat 29: 11, 2020.
-
17.
Akkus A, Demirseren DD, Demirseren ME, et al: The treatment of ingrown nail: chemical matricectomy with NAOH versus wedge resection. Dermatol Ther 31: e12677, 2018.
-
18.
Wu Y, Fu C, Zhang W, et al: The Dermatology Life Quality Index (DLQI) and the Hospital Anxiety and Depression (HADS) in Chinese rosacea patients. Psychol Health Med 23: 369, 2018.
-
19.
Dalgard FJ, Svensson Å, Gieler U, et al: Dermatologists across Europe underestimate depression and anxiety: results from 3635 dermatological consultations. Br J Dermatol 179: 464, 2018.
-
20.
Williamson L, Dalbeth N, Dockerty J, et al: nail disease in psoriatic arthritis—clinically important, potentially treatable and often overlooked. Rheumatology 43: 790, 2004.
-
21.
Fernandez‐Peñas P, Jones‐Caballero M, Espallardo O, et al: Comparison of Skindex‐29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis. Br J Dermatol 166: 884, 2012.
-
22.
Takahashi N, Suzukamo Y, Nakamura M, et al: Japanese version of the Dermatology Life Quality Index: validity and reliability in patients with acne. Health Qual Life Outcomes 4: 46, 2006.
Effect of Nail Disorders on Quality of Life Scale Scores: A Prospective, Cross-sectional Study from a Tertiary Referral Center
Search for other papers by Efsun Tanacan in
Current site
Google Scholar
PubMed
Search for other papers by Fatma Gulru Erdogan in
Current site
Google Scholar
PubMed
Background: To investigate the relationships among nail disorders, various clinical factors, and commonly used quality of life scales.
Methods: A prospective cross-sectional study was conducted on 188 patients older than 18 years who applied to the Dermatology and Venereology Department of Ufuk University Hospital (Ankara, Turkey). The Turkish Quality of Life instrument, the Hospital Anxiety and Depression Scale, and the 36-Item Short-Form Health Survey were used for the analyses. Eight groups were formed based on 1) sex, 2) age (18–45 years, >45 years), 3) duration of nail disease (≤1 year, >1 year), 4) number of affected nails (1, 2, ≥3), 5) type of nail disease (nail thickening, ingrown toenail, pincer nail, and other nail diseases), 6) presence of onychomycosis, 7) fingernail involvement, and 8) pain score (0–5, 6–10), and the quality of life scales were compared between these groups. In addition, correlation analyses were performed between age, number of affected nails, duration of disease, presence of onychomycosis, chronic diseases and medications, and body mass index and the quality of life scale scores.
Results: Nail disorders were associated with decreased quality of life in affected individuals. Moreover, age, duration of disease, type of nail disorder, body mass index, comorbid conditions, and pain scores had significant effects on quality of life scale scores.
Conclusions: Management of nail disorders is challenging, and generally, a long period is necessary to achieve favorable outcomes. Both physcians and patients should be persistent during the treatment process. In addition, emotional and social support should be provided to patients.
advertising
